2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert T, Loeb S, Cooperberg M, Catalona W, Sprenkle P, Kim I, Leapman M. Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars And Original Investigations 2024, 43: 193.e19-193.e26. PMID: 39706698, DOI: 10.1016/j.urolonc.2024.11.007.Peer-Reviewed Original ResearchMeSH KeywordsAgedHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleMiddle AgedNeoplasm GradingProstateProstatectomyProstatic NeoplasmsRetrospective StudiesConceptsPI-RADS 5 lesionsGG1 prostate cancerPI-RADSGG1 diseaseFusion biopsyRadical prostatectomyGleason gradeProstate cancerActive surveillanceGrade Group 1 prostate cancerSingle-institution retrospective analysisOptimal management of patientsMRI-ultrasound fusion biopsyLong-term outcome dataProstate Imaging ReportingMultivariate modelGenomic classifier scoresManagement of patientsPrimary study outcomeAssociated with upgradingMulti-institutional dataGleason upgradingTumor upgradingSurveillance biopsiesProstate MRIConventional and Contrast-enhanced US of the Lung: From Performance to Diagnosis.
Jiménez-Serrano S, Páez-Carpio A, Doménech-Ximenos B, Cornellas L, Sánchez M, Revzin M, Vollmer I. Conventional and Contrast-enhanced US of the Lung: From Performance to Diagnosis. RadioGraphics 2024, 44: e230171. PMID: 38935548, DOI: 10.1148/rg.230171.Peer-Reviewed Original ResearchMeSH KeywordsContrast MediaDiagnosis, DifferentialHumansImage EnhancementImage-Guided BiopsyLungLung DiseasesUltrasonographyConceptsPeripheral lung diseaseContrast-enhanced USDiagnosis of peripheral lung diseasePercutaneous biopsyLung USEnhancement patternLung diseaseImage-guided percutaneous biopsyAccurate differential diagnosisDiagnostic chest imagingLung biopsySubpleural lesionsConventional USDifferential diagnosisPathological findingsPulmonary physiologyChest imagingArterial supplyBiopsyLungDiagnostic testsDiagnosisSoft tissueDiseaseImaging time
2023
Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy
Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg M, Sprenkle P, Leapman M. Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectrum 2023, 7: pkad099. PMID: 38085220, PMCID: PMC10733209, DOI: 10.1093/jncics/pkad099.Peer-Reviewed Original ResearchConceptsMagnetic resonance imaging-ultrasound fusionMRF-TBLow-risk diseaseSystematic biopsyLower riskRisk groupingProstate biopsyActive surveillanceHigh riskProstate cancer risk stratificationIntermediate-risk criteriaIntermediate-risk diseaseSystematic prostate biopsyCancer risk stratificationPrimary study objectiveNCCN guidelinesImage-guided approachLocalized cancerRisk stratificationBenign findingsProstate cancerClinical riskDiagnostic yieldRetrospective analysisBiopsyEnvironmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy
Leapman M, Thiel C, Gordon I, Nolte A, Perecman A, Loeb S, Overcash M, Sherman J. Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy. European Urology 2023, 83: 463-471. PMID: 36635108, DOI: 10.1016/j.eururo.2022.12.008.Peer-Reviewed Original ResearchConceptsProstate magnetic resonance imagingMagnetic resonance imagingSystematic biopsyProstate biopsyProstate biopsy procedureResonance imagingBiopsy coresTransrectal Ultrasound Guided Prostate BiopsyBiopsy procedureMultiparametric magnetic resonance imagingUnnecessary prostate biopsiesBiparametric magnetic resonance imagingOutpatient urology clinicNumber of biopsiesGuided Prostate BiopsyAcademic medical centerHealth care facilitiesEvidence-based approachUrology clinicClinical managementMedical CenterTriage strategiesClinical careTransrectal ultrasoundBiopsy
2022
Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer
Lokeshwar SD, Nguyen J, Rahman SN, Khajir G, Ho R, Ghabili K, Leapman MS, Weinreb JC, Sprenkle PC. Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer. Urologic Oncology Seminars And Original Investigations 2022, 40: 407.e21-407.e27. PMID: 35811206, DOI: 10.1016/j.urolonc.2022.06.005.Peer-Reviewed Original ResearchMeSH KeywordsHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleProstate-Specific AntigenProstatic NeoplasmsRetrospective StudiesWatchful WaitingConceptsActive surveillanceIndex lesionProstate biopsyProstate cancerMultiparametric magnetic resonance imagingData System version 2Low-risk CaPSurveillance prostate biopsyGleason grade groupMultivariate logistic regressionSignificant prostate cancerProstate Imaging ReportingReceiver operator characteristic curvePI-RADS 2Low-suspicion lesionsOperator characteristic curveMagnetic resonance imagingHigher PSADOnly significant variablePrimary outcomeMultivariable analysisSystematic biopsyRetrospective analysisBiopsy approachImaging Reporting
2021
Extent of High-Grade Prostatic Adenocarcinoma in Multiparametric Magnetic Resonance Imaging-Targeted Biopsy Enhances Prediction of Pathologic Stage.
Paulson N, Vollmer RT, Humphrey PA, Sprenkle PC, Onofrey J, Huber S, Amirkhiz K, Levi AW. Extent of High-Grade Prostatic Adenocarcinoma in Multiparametric Magnetic Resonance Imaging-Targeted Biopsy Enhances Prediction of Pathologic Stage. Archives Of Pathology & Laboratory Medicine 2021, 146: 201-204. PMID: 34015819, DOI: 10.5858/arpa.2020-0568-oa.Peer-Reviewed Original ResearchConceptsMpMRI-targeted biopsiesHigh-grade prostatic adenocarcinomaMultiparametric magnetic resonance imagingHG PCaRadical prostatectomyHigh-grade groupMagnetic resonance imagingPathologic stageRP outcomesProstatic adenocarcinomaGrade Group 2 diseaseResonance imagingGrade groupProstate-confined diseaseSeminal vesicle involvementLymph node metastasisHigher pathologic stageAdditional predictive valueLogistic regression modelsLinear millimeterNode metastasisRetrospective reviewAdverse outcomesTargeted biopsiesProstate biopsyThe impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis
Surasi DSS, Wang X, Bathala TK, Hwang H, Arora S, Westphalen AC, Chang SD, Turkbey B. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis. Abdominal Radiology 2021, 46: 4362-4369. PMID: 33904992, PMCID: PMC8077193, DOI: 10.1007/s00261-021-03087-8.Peer-Reviewed Original ResearchConceptsBowel preparationMedian numberProstate MRICoronavirus disease 2019 (COVID-19) pandemicCOVID-19Disease 2019 pandemicCOVID-19 pandemicHealth care systemComplete responseMedical oncologyProstate biopsyClinic schedulesProstate cancerMRI studiesLockdown periodCare systemCollateral damageRadiation oncologyClinical departmentsPanel survey analysisMRIBiopsyRadiology departmentOncologyDescriptive statisticsA Retrospective Multi-Site Academic Center Analysis of Pneumothorax and Associated Risk Factors after CT-Guided Percutaneous Lung Biopsy
Rong E, Hirschl D, Zalta B, Shmukler A, Krausz S, Levsky J, Lin J, Haramati L, Gohari A. A Retrospective Multi-Site Academic Center Analysis of Pneumothorax and Associated Risk Factors after CT-Guided Percutaneous Lung Biopsy. Lung 2021, 199: 299-305. PMID: 33876295, DOI: 10.1007/s00408-021-00445-7.Peer-Reviewed Original ResearchConceptsChest tube placementLung biopsyPneumothorax riskTube placementRisk factorsSmaller lesion sizeLung surgeryLesion sizeSubcutaneous tissueCT-guided lung biopsyPercutaneous lung biopsyFrequency of complicationsAssociated risk factorsChest X-rayImmediate pneumothoraxSmoking historyDelayed pneumothoraxLung cancerChest radiographsWall biopsyPneumothoraxPatientsBiopsyBiopsy techniqueCenter analysis
2020
The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials
Tam AL, Papadimitrakopoulou V, Wistuba II, Lee JJ, Ensor JE, Kim ES, Kalhor N, Blumenschein GR, Tsao AS, Heymach JV, Herbst RS, Hicks ME, Hong WK, Gupta S. The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials. Clinical Radiology 2020, 76: 155.e25-155.e34. PMID: 33268083, DOI: 10.1016/j.crad.2020.09.024.Peer-Reviewed Original ResearchConceptsInterventional radiologistsClinical trial teamsTrial teamPercutaneous image-guided biopsyLung Cancer EliminationLung cancer trialsEvidence of viabilityImage-guided biopsyLesion scoring systemBiomarker analysisCancer trialsTargeted therapyCancer eliminationScore's abilityInterventional radiologyMultivariate analysisLesionsBiopsySolid massFollowing criteriaModerate agreementMultidisciplinary approachTrialsScoresBiomarkersFourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
Sterling J, Smith K, Farber N, Nagaya N, Jang TL, Singer EA, Sadimin E, Kim IY. Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience. Clinical Genitourinary Cancer 2020, 19: 275-279. PMID: 33153920, DOI: 10.1016/j.clgc.2020.09.006.Peer-Reviewed Original ResearchMeSH KeywordsBiopsy, Large-Core NeedleHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleNeoplasm GradingProstatic NeoplasmsConceptsSystematic prostate biopsyProstate cancerProstate biopsyGleason scoreBiopsy resultsAnterior coreElevated prostate-specific antigenMagnetic resonance imaging-ultrasound fusion biopsyHigh-risk prostate cancerStandard template biopsyPercent of patientsSingle institution experienceC prostate cancerCsPCa detection ratesPositive biopsy resultsCancer detection rateSignificant prostate cancerProstate Imaging ReportingPI-RADS lesionsProstate-specific antigenTemplate prostate biopsyDetection rateMagnetic resonance imagingOverall detection rateSystematic biopsyRadiologic-Pathologic Correlation for Nondiagnostic CT-Guided Lung Biopsies Performed for the Evaluation of Lung Cancer.
Ma Y, Byrne SC, Gange C, Hunsaker AR, Hammer MM. Radiologic-Pathologic Correlation for Nondiagnostic CT-Guided Lung Biopsies Performed for the Evaluation of Lung Cancer. American Journal Of Roentgenology 2020, 215: 116-120. PMID: 32160056, DOI: 10.2214/ajr.19.22244.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overFemaleHumansImage-Guided BiopsyLung NeoplasmsMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedConceptsLung biopsyPathology resultsThoracic radiologistsRepeat biopsyAtypical cellsHerder modelCT-guided lung biopsyRadiologic-pathologic concordanceNormal lung tissuesCases of inflammationLung malignancyRetrospective studyFinal diagnosisLung cancerLung tissuePathologic correlationBiopsyMalignancyROC curvePneumoniaPatientsLower ratesHigh rateRadiologistsScores
2019
Ultrasound-Guided Transthoracic Fine-Needle Aspiration: A Reliable Tool in Diagnosis and Molecular Profiling of Lung Masses
Rodriguez EF, Pastorello R, Osmani L, Hopkins M, Kryatova M, Kawamoto S, Maleki Z. Ultrasound-Guided Transthoracic Fine-Needle Aspiration: A Reliable Tool in Diagnosis and Molecular Profiling of Lung Masses. Acta Cytologica 2019, 64: 208-215. PMID: 31362293, DOI: 10.1159/000501421.Peer-Reviewed Original ResearchConceptsLung massPulmonary adenocarcinomaMedical recordsTransthoracic fine needle aspirationConcurrent core biopsyAdvanced stage diseaseInstitutional review board approvalMajority of patientsTransthoracic needle aspirationCarcinoma/adenocarcinomaPatients' medical recordsFine-needle aspirationReview board approvalStage diseaseCommon diagnosisMean agePulmonary lesionsCore biopsyMalignant diagnosisNeedle aspirationPrior historyCytologic diagnosisInvasive proceduresBoard approvalCytology specimensPI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway
Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, Thoeny HC, Cornud F, Haider M, Macura K, Tempany C, Verma S, Weinreb J. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology 2019, 292: 464-474. PMID: 31184561, PMCID: PMC6677282, DOI: 10.1148/radiol.2019182946.Peer-Reviewed Original ResearchConceptsBiopsy pathwayProstate cancerLife-threatening prostate cancerBiopsy-naive menNegative biopsy resultsClinical care guidelinesHigh-quality evidenceSignificant prostate cancerRoutine clinical practiceProstate Imaging ReportingGreater clinical utilityNumber of diagnosesProstate cancer detectionClinical suspicionInsignificant cancerCare guidelinesBiopsy resultsProstate biopsyTransrectal USMRI pathwayPositive health impactsNumber of menBiopsy increasesIncorporation of MRIClinical utilityRole of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy
Lu AJ, Syed JS, Ghabili K, Hsiang WR, Nguyen KA, Leapman MS, Sprenkle PC. Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy. European Urology 2019, 76: 14-17. PMID: 31047733, DOI: 10.1016/j.eururo.2019.04.008.Peer-Reviewed Original ResearchConceptsFusion prostate biopsySignificant prostate cancerProstate cancerProstate biopsyFusion biopsyMagnetic resonance imaging-ultrasound fusion biopsyActive surveillance patientsProstate Imaging ReportingUltrasound fusion biopsyMultiparametric MRI studyMagnetic resonance imagingClinical suspicionSurveillance patientsFirst biopsySystematic biopsySignificant cancerMRI studiesBiopsyPatientsRegion of interestImaging ReportingResonance imagingCancerDistinct cohortsSuspicious areas
2018
Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies
Martin DT, Ghabili K, Levi A, Humphrey PA, Sprenkle PC. Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies. Urology 2018, 125: 64-72. PMID: 30552940, DOI: 10.1016/j.urology.2018.12.001.Peer-Reviewed Original ResearchConceptsPI-RADSv2 scoreDecipher scoreProstate Imaging ReportingDecipher testingTargeted biopsiesRadical prostatectomyData System version 2 (PI-RADS v2) scoreFavorable intermediate-risk prostate cancerIntermediate-risk prostate cancer patientsGleason Grade Group 1Imaging ReportingIntermediate-risk prostate cancerMultivariable logistic regression analysisHigh-risk diseasePI-RADS 4Grade group 1Gleason grade groupProstate cancer patientsMultiparametric magnetic resonancePI-RADS scoreVersion 2 scoreData System scoreLogistic regression analysisSignificant differencesPI-RADS categoryTranscriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound‐Guided Synovial Biopsies in Rheumatoid Arthritis
Mandelin AM, Homan PJ, Shaffer AM, Cuda CM, Dominguez ST, Bacalao E, Carns M, Hinchcliff M, Lee J, Aren K, Thakrar A, Montgomery AB, Bridges SL, Bathon JM, Atkinson JP, Fox DA, Matteson EL, Buckley CD, Pitzalis C, Parks D, Hughes LB, Geraldino‐Pardilla L, Ike R, Phillips K, Wright K, Filer A, Kelly S, Ruderman EM, Morgan V, Abdala‐Valencia H, Misharin AV, Budinger GS, Bartom ET, Pope RM, Perlman H, Winter DR. Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound‐Guided Synovial Biopsies in Rheumatoid Arthritis. Arthritis & Rheumatology 2018, 70: 841-854. PMID: 29439295, PMCID: PMC5984677, DOI: 10.1002/art.40453.Peer-Reviewed Original ResearchMeSH KeywordsAgedArthritis, RheumatoidFemaleHumansImage-Guided BiopsyMacrophagesMaleMiddle AgedSynovial MembraneTranscription, GeneticUltrasonographyConceptsPrecision medicine-based approachSynovial tissue biopsiesRheumatoid arthritisSynovial tissueSynovial biopsiesSynovial macrophagesBiopsy specimensTissue biopsiesRA synovial macrophagesSynovial biopsy specimensMinimal adverse effectsDisease activityRA patientsClinical parametersInvasive ultrasoundTherapeutic responseFluorescence-activated cell sortingClinical informationPatientsReliable biomarkersTranscriptional profilesBiopsyHistologic analysisMacrophage populationsReproducible biomarkersMRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI. American Journal Of Roentgenology 2018, 210: w218-w225. PMID: 29489409, DOI: 10.2214/ajr.17.18680.Peer-Reviewed Original ResearchConceptsPI-RADS 5 lesionsBenign pathologic resultsLower prostate-specific antigen densitySignificant prostate cancerProstate-specific antigen densityBenign prostatic hyperplasia nodulesMRI-ultrasound fusionProstate Imaging ReportingCategory 5 lesionsPathologic resultsProstate cancerClinical featuresBenign diseaseAntigen densityImaging ReportingGleason 6 diseasePI-RADS version 2High-risk lesionsMultivariate logistic regressionRoutine clinical interpretationMultiparametric prostate MRIInflammatory changesNormal anatomic structuresBiopsy resultsTargeted biopsies
2017
Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
Sheridan AD, Nath SK, Syed JS, Aneja S, Sprenkle PC, Weinreb JC, Spektor M. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI. American Journal Of Roentgenology 2017, 210: 347-357. PMID: 29112469, DOI: 10.2214/ajr.17.18516.Peer-Reviewed Original ResearchConceptsCategory 3 lesionsData System (BI-RADS) category 3 lesionsPI-RADS category 3 lesionsMultiparametric prostate MRIRisk factorsProstate Imaging ReportingProstate MRIAbnormal digital rectal examination findingsPredictive valueImaging ReportingDigital rectal examination findingsClinically Significant Prostate CancerMultivariate logistic regression modelPI-RADS category 3Smaller prostate volumePI-RADS version 2Older patient ageRectal examination findingsMore risk factorsRisk stratification algorithmMRI-ultrasound fusionSignificant prostate cancerNegative predictive valuePositive predictive valueLogistic regression modelsA rare ‘incidentaloma’ found on low-dose CT screening for lung cancer: ‘scanner beware’
Federman DG, Baldassarri RJ, Cain HC. A rare ‘incidentaloma’ found on low-dose CT screening for lung cancer: ‘scanner beware’. Postgraduate Medicine 2017, 129: 653-656. PMID: 28562187, DOI: 10.1080/00325481.2017.1334506.Peer-Reviewed Original ResearchConceptsLow-dose computed tomographyCell histiocytosisLung cancerU.S. Preventive Services Task ForcePack-year smoking historyPulmonary Langerhans cell histiocytosisLangerhans cell histiocytosisYears of ageLow-dose CTCurrent smokersSmoking historyComputed tomographyAdults 55CancerTask ForceIncidentalomasSmokersHistiocytosisMalignancyYearsMortalityAbnormalitiesOverwhelming majorityCTProstate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion–targeted biopsy in patients with a solitary PI-RADS v2–scored lesion
Syed JS, Nguyen KA, Nawaf CB, Bhagat AM, Huber S, Levi A, Humphrey P, Weinreb JC, Schulam PG, Sprenkle PC. Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion–targeted biopsy in patients with a solitary PI-RADS v2–scored lesion. Urologic Oncology Seminars And Original Investigations 2017, 35: 542.e19-542.e24. PMID: 28501565, DOI: 10.1016/j.urolonc.2017.04.011.Peer-Reviewed Original ResearchMeSH KeywordsHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleMiddle AgedProstateProstatic NeoplasmsUltrasonographyConceptsPositive predictive valueProstate cancerGleason scoreSuspicious findingsMultiparametric magnetic resonance imagingProstate multiparametric magnetic resonance imagingPeripheral zoneHigh positive predictive valueFusion-targeted biopsyProstate Imaging ReportingPI-RADS v2Category 4 lesionsMagnetic resonance imagingProstate zonal anatomySystematic biopsyProstate biopsyFusion biopsySingle lesionPatientsBiopsyPredictive valueImaging ReportingResonance imagingLesionsCancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply